Jacques Le Lorier

Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews

David Moher, Paul R. Fortin, Alejandro R. Jadad et al. · The Lancet · 1996 · 538 citations

Pharmacy, English, Evidence-based Practice +11

Selecting the language of the publications included in a meta-analysis: Is there a tower of babel bias?

Geneviève Grégoire, François Derderian, Jacques Le Lorier · Journal of Clinical Epidemiology · 1995 · 538 citations

Public Health, Biostatistics, Meta-analysis +8

Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic Therapy

Penny S. Albright, Scott W Livingstone, David L. Keegan et al. · Clinical Drug Investigation · 1996 · 66 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

Modifiable factors predicting patient survival in elderly kidney transplant recipients

Héloïse Cardinal, Marie‐Josée Hébert, Elham Rahme et al. · Kidney International · 2005 · 53 citations · Full text

Medicine, Geriatric Medicine, Nephrology +16

Clinical Study of a New Antikeloid Agent

Jean-Paul Bossé, J Papillon, Gilles Frenette et al. · Annals of Plastic Surgery · 1979 · 40 citations

Medicine, Dermatology, Surgery +17